Thus, PTPN2 knockdown significantly reduced proliferation and promoted apoptosis in KRAS-dependent cancer cells (HCT-116, PaTu8988T, and H460), but not in KRAS-independent cells [62]. The gene discussed is KRAS; the disease is cancer.